Literature DB >> 2612303

Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects.

J N Kostraba1, J S Dorman, T J Orchard, D J Becker, Y Ohki, D Ellis, B H Doft, L A Lobes, R E LaPorte, A L Drash.   

Abstract

The contribution of diabetes duration, both pre- and postpuberty, to the development of microvascular complications and mortality in diabetic subjects was investigated in three study populations from the Children's Hospital of Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Registry. Life-table analyses by total and postpubertal IDDM duration were used to evaluate differences in the prevalence of microvascular complications and diabetes-related mortality in subjects diagnosed before and during puberty, as defined by an age at IDDM onset marker of 11 yr for girls and 12 yr for boys. The prevalence of retinopathy and overt nephropathy in 552 White adult diabetic subjects (population 1, mean IDDM duration 20.8 yr was significantly greater in subjects diagnosed during puberty compared with those diagnosed before puberty. However, similar analyses by postpubertal duration showed no difference in microvascular complication prevalence between the two groups. These findings did not appear to be due to a confounding effect of age. Additional analyses of 239 adolescent diabetic subjects (population 2, mean duration 8.3 yr) revealed the same trend for the prevalence of retinopathy. Finally, results concerning the risk of diabetes-related mortality in a cohort of 1582 subjects (population 3, mean duration 12.9 yr) indicated that postpubertal duration of IDDM may be a more accurate determinant of the development of microvascular complications and diabetes-related mortality than total duration, and it is suggested that the contribution of the prepubertal years of diabetes to long-term prognosis may be minimal.

Entities:  

Mesh:

Year:  1989        PMID: 2612303     DOI: 10.2337/diacare.12.10.686

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients.

Authors:  H P Hammes; W Kerner; S Hofer; O Kordonouri; K Raile; R W Holl
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

Review 2.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

3.  All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973-2013.

Authors:  Vibeke Gagnum; Lars C Stene; Leiv Sandvik; Morten W Fagerland; Pål R Njølstad; Geir Joner; Torild Skrivarhaug
Journal:  Diabetologia       Date:  2015-05-14       Impact factor: 10.122

4.  The infant and toddler with diabetes: Challenges of diagnosis and management.

Authors:  D Daneman; M Frank; K Perlman; J Wittenberg
Journal:  Paediatr Child Health       Date:  1999-01       Impact factor: 2.253

Review 5.  Glycemic control and complications of diabetes mellitus.

Authors:  I B Hirsch
Journal:  West J Med       Date:  1995-05

6.  Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus.

Authors:  C A Jones; G P Leese; S Kerr; K Bestwick; D I Isherwood; J P Vora; D A Hughes; C Smith
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

7.  Kidney disease in childhood-onset diabetes.

Authors:  Robert G Nelson
Journal:  Am J Kidney Dis       Date:  2008-08-03       Impact factor: 8.860

8.  Age at onset and the risk of proliferative retinopathy in type 1 diabetes.

Authors:  Kustaa Hietala; Valma Harjutsalo; Carol Forsblom; Paula Summanen; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

9.  A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients.

Authors:  G Joner; O Brinchmann-Hansen; C G Torres; K F Hanssen
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

10.  Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).

Authors: 
Journal:  BMC Pediatr       Date:  2009-12-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.